Vaccines Receives an Increased CiteScore of 8.9

We are pleased to inform you that Vaccines (ISSN: 2076-393X) has received a heightened CiteScore of 8.9.

CiteScore provides transparent metrics that enable well-informed publishing strategy, library collection development, and the benchmarking of journal performance. It is now a standard citation metric alongside SNIP and SJR that gives an up-to-date view of a journal’s impact.

The 2023 CiteScore provides an assessment of the scientific influence of journals in the 2020 to 2023 period. This is a reflection of the excellent performance, support, and dedication of all journal editors, reviewers, authors, and readers.

Vaccines’s CiteScore ranks as follows:

Q1 (27 out of 272) in the “Pharmacology (medical)” category;
Q1 (56 out of 344) in the “Infectious Diseases” category;
Q1 (51 out of 313) in the “Pharmacology” category;
Q1 (28 out of 157) in the “Drug Discovery” category;
Q2 (68 out of 236) in the “Immunology” category.

For more journal statistics, please visit https://www.mdpi.com/journal/vaccines/stats.

Thank you to everyone who has contributed to the journal.

Vaccines Editorial Offices